Back | Next |
home / stock / aim / aim message board
Subject | By | Source | When |
---|---|---|---|
$AIM ImmunoTech to Present at the Virtual Investor | mick | investorshub | 07/17/2022 10:10:17 PM |
$AIM Aerosonic Common Stock ($0.40 Par Value) | mick | investorshub | 07/17/2022 10:10:05 PM |
Stop loss done pumpit Friday. | carldfw | investorshub | 06/09/2022 7:00:26 PM |
Stop loss done pumpit Friday. | carldfw | investorshub | 06/09/2022 7:00:23 PM |
$AIM ImmunoTech Inc ($AIM) | mick | investorshub | 06/05/2022 5:51:21 AM |
$AIM ImmunoTech Inc ($AIM) | mick | investorshub | 05/01/2022 8:06:02 PM |
$AIM ImmunoTech Inc. (NYSE: American $AIM) ($AIM or | crudeoil24 | investorshub | 04/25/2022 10:57:53 AM |
https://www.otcmarkets.com/stock/$AIM | mick | investorshub | 03/12/2022 9:19:59 PM |
$AIM ImmunoTech Inc ($AIM) | mick | investorshub | 03/12/2022 7:22:34 PM |
$AIM ImmunoTech Inc ($AIM) | mick | investorshub | 02/05/2022 10:45:00 PM |
https://www.otcmarkets.com/stock/$AIM | mick | investorshub | 01/02/2022 10:15:30 PM |
https://www.otcmarkets.com/stock/$AIM | mick | investorshub | 12/11/2021 10:12:08 PM |
$AIM ImmunoTech Inc ($AIM) | mick | investorshub | 11/06/2021 4:48:42 PM |
https://www.otcmarkets.com/stock/$AIM | mick | investorshub | 10/09/2021 5:27:52 PM |
$AIM ImmunoTech Inc ($AIM) | mick | investorshub | 09/22/2021 11:44:38 PM |
$AIM ImmunoTech Inc ($AIM) | mick | investorshub | 08/14/2021 8:04:57 PM |
Sign this petition for Ampligen approval http://chng.it/ntCkN45ppP | Richard2 | investorshub | 07/31/2021 12:32:14 AM |
znewcar1: Does AIM hold $2? not looking good. | znewcar1 | investorshangout | 07/26/2021 6:52:18 PM |
Lovely 70g sell maybe news wed | carldfw | investorshub | 07/24/2021 10:29:34 PM |
$AIM seems to have a hand off drug | swampboots | investorshub | 07/21/2021 12:51:53 AM |
News, Short Squeeze, Breakout and More Instantly...
AIM ImmunoTech Inc. Company Name:
AIM Stock Symbol:
NYSE Market:
OCALA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has taken an essential step forward in testing the combination of AIM’s Ampligen® (rintatolimod) and AstraZ...
OCALA, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM") today announced that Charles Lapp, MD, is joining the co...
OCALA, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced that Charles Lapp, MD, is joining the company to help lead its efforts to develop Ampligen (rintatolimod) as a potential treatment for Myalgic encephalomyelit...